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Anemia and the Blood Donor
The World Health Organization recommends a collection rate of 10-20 whole blood 
units per 1000 inhabitants to address transfusion needs(1). However, demand for blood is 
ever-increasing as medicine continuous to develop(2).
Donor selection is critical to blood transfusion safety and blood donor eligibility 
policies are designed to protect both the donor and the recipient(1,3). Donors with relatively 
low hemoglobin (Hb) levels are not allowed to donate to prevent them from developing iron 
deficiency anemia (IDA). In addition, deferral of these donors guarantees that blood units for 
transfusion meet the required standards for Hb content(4).
Deferral for low Hb accounts for 35% to 75% of total deferrals, with the vast majority 
occurring in women(5-7). At the New York Blood Center, 92.7% of these deferrals were women(6,7).
Iron deficiency is the world’s most widespread nutritional disorder, affecting both 
industrialized and developing countries(8). In Brazil, there are no consistent studies to show the 
real problem, although some studies showed 25% of anemia in women of childbearing age(9,10).
On the other hand, because IDA is the last stage of iron-deficiency, Hb measurement 
alone is inadequate to detect blood donors with iron deficiency but without anemia. Recent 
publications have suggested that serum ferritin levels could be a reliable indicator for body 
iron stores since they provide a determination of iron deficiency at an early stage(11,12).
As ferritin testing is comparatively costly, various red blood cell (RBC) parameters have 
been proposed as markers for low ferritin/iron depletion(13). Significant correlations between 
ferritin and RBC parameters were shown in these analyses, but no study has determined which 
marker is the most useful to identify donors at risk of developing anemia(13).
Beta-thalassemia trait (BTT) is the second most common cause of microcytic anemia and, 
for this reason, the possibility of this disease must be discarded when anemia or microcytosis 
is present(12,14). An interesting paper by Tiwari et al.(14) suggested that it could be useful to 
routinely perform a complete blood count (CBC) for all blood donors and further analyze the 
microcytic samples for ferritin and Hemoglobin A2 to differentiate between IDA and BTT. 
This approach, however, is relevant only in areas where there is an elevated prevalence of 
BTT. These authors, also, reviewed nine indices to differentiate IDA and BTT. (Table 1)
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Table 1 - Formulae and cut-off point of nine indices to differentiate iron deficiency 
anemia (IDA) and beta-thalassemia trait (BTT)(14)
Index Formula In favor ofIDA BTT
RBC x 109/μL < 5 > 5
RDW % > 14 < 14
Mentzer MCV/RBC > 13 < 13
Shine and Lal MCV2 x MCH x 0.01 > 1530 < 1530
England and Fraser MCV – RBC – (5 Hb) – 3.4 Positive Negative
Srivastava MCH/RBC > 3.8 < 3.8
Green and King MCV2 x RDW/100 x Hb > 65 < 65
RDW index MCV x RDW/RBC > 220 < 220
Ricerca RDW/RBC > 4.4 < 4.4
RBC: Red blood cells; RDW: Red blood cell distribution width; MCV: Mean corpuscular volume; 
MCH: Mean corpuscular hemoglobin
In order to fulfill their necessities, blood centers have long recognized that it is more 
effective and less expensive to collect blood from existing donors than to recruit new donors 
and in the United States, 71% of donors are repeat donors. But, this strategy has come at a 
price: iron depletion of these donors(5). After donation of 450 mL of blood, a male donor loses 
242 ± 17 mg and a female 217 ± 11 mg of iron(5,15). Since the 1970s, various investigators 
documented the decrease in serum ferritin levels in association with blood donation(5,11,13,16-18).
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The lost iron is not readily repleted. It has been common 
practice for blood centers to recommend iron-rich diets to donors 
who have been rejected for low Hb. However, even with excellent 
compliance, it requires 6 months or longer to positively impact 
ferritin levels(5). Because of this, many researches have prescribed 
iron supplementation with good results(15,19,20). However, the 
majority of regular blood donors with low or absent iron stores 
will never develop IDA(13).
It is important to remember that avoiding unnecessary 
deferrals, keeps donors engaged with the blood center(6). In fact, 
Boulton demonstrated that only 25% of first-time donors return 
to the blood donation facility after rejection, while 47% of first-
time donors come back within 6 months when accepted at their 
first visit(21).
Anemia is an important topic for blood donor candidates and 
effort has to be made to identify these individuals, prevent iron 
depletion in regular blood donors, and engage these individuals 
with blood donation.
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